Revised MRPs post GST rate reduction, effective 22nd September – Making healthcare more affordable. Learn More
Press Release

Mankind Pharma Blends Ayurvedic Heritage and Modern Wellness with Manforce Upakarma

Share

Mankind Pharma has announced the launch of Manforce Upakarma Shilajit Gold Dust, a premium Ayurvedic formulation that brings together the trusted legacy of Upakarma with the Manforce brand’s deep connection to men’s health and wellness in India.

The product is a special edition resin-form Shilajit enriched with gold dust, available in a 10g jar. It contains more than 60% Fulvic Acid and over 85 essential minerals, with the raw material sourced globally rather than being limited to a single geography, a distinction the brand makes to underline its commitment to consistent purity and potency.

Designed as a performance-focused wellness formulation for men, the product is built around three key pillars. On the physical side, it is positioned to support stamina, energy and overall strength. For mental wellness, the formulation is designed to help support stress management and cognitive well- being. On the lifestyle front, it contains antioxidant-rich ingredients associated with healthy ageing,
positioning it as a comprehensive wellness-focused product rather than a single-use supplement.

“The men’s wellness category in India is evolving rapidly, and consumers are increasingly looking for products that are rooted in Ayurvedic science but formulated to meet modern standards of quality and efficacy. Manforce Upakarma Shilajit Gold Dust is our answer to that demand. By bringing Upakarma’s formulation expertise under the Manforce umbrella, we are able to offer something that combines centuries of Ayurvedic tradition with the credibility and reach that Manforce commands across India,” said Joy Chatterjee, Vice President and Head of Sales and Marketing, Mankind Consumer Products Private Limited

Manforce Upakarma Shilajit Gold Dust is available across quick commerce platforms

About Mankind Pharma

Mankind Pharma (BSE: 543904 | NSE: MANKIND) is one of the largest pharmaceutical company in India, which focuses on the domestic market with its Pan India presence. Mankind operates at the intersection of the Indian pharmaceutical formulations and consumer healthcare sectors with the aim of providing quality products at affordable prices. The company is a leading player in the
domestic pharmaceuticals business present across acute and chronic therapeutic areas including anti-infectives, cardiovascular, gastrointestinal, antidiabetic, neuro/CNS, gynaecology, VMN and respiratory, among others with a strategy to increase chronic presence going ahead. In the consumer healthcare business, the company operates in the condoms, pregnancy detection, emergency contraceptives, antacid powders, vitamin and mineral supplements and anti-acne preparations categories, among others, with several category-leading brands. Following the acquisition of BSV, Mankind Pharma has further strengthened its leadership in the domestic women’s health segment. Mankind’s distribution network includes a robust field force of 18,500+ professionals, and a reach extending to over five lakh doctors across urban and rural markets. The company has 32 manufacturing facilities in India manufacturing a wide range of dosage forms, including tablets, capsules, syrups, vials, ampoules, blow fill seal, soft and hard gels, eye drops, creams, contraceptives and other over-the-counter products. Mankind has a consistent track record of product innovation through 7 dedicated R&D facilities backed by more than 750 scientists. For more information, visit www.mankindpharma.com

For more information, visit www.mankindpharma.com or contact:
Natasha Raj – 9205057627 – natasha.raj@mankindpharma.com
Apoorva Sharma – 9999739452 – apoorva.sharma@adfactorspr.com